期刊文献+

肺移植术后肺部感染的研究现状 被引量:8

The present research status on pulmonary infections after lung transplantation
原文传递
导出
摘要 肺移植已成为治疗各种终末期肺部疾病的有效方式,可以显著改善患者生命质量,延长生存时间。但目前肺移植术后管理还存在诸多挑战,其中肺部感染是影响受者术后生存和生命质量的首要因素。本文综述了国内外肺移植术后受者常见感染类型及危险因素,以期为临床肺移植感染的预防和治疗提供借鉴。 Lung transplantation has become an effective treatment for various end-stage lung diseases,which can significantly improve the quality of life and prolong the survival time of patients.However,there are still many challenges in the postoperative management of lung transplantation,which pulmonary infection is the primary factor affecting the survival and quality of life of recipients.This article reviews the common infection types and risk factors of lung transplantation recipients at home and abroad,in order to provide reference for the prevention and treatment of clinical lung transplantation infection.
作者 王文静 李小杉 钱婷 杨航 陈静瑜 吴波 WANG Wenjing;LI Xiaoshan;QIAN Ting;YANG Hang;CHEN Jingyu;WU Bo(Wuxi People's Hospital Affiliated to Nanjing Medical University,Wuxi,Jiangsu 214023,P.R.China)
出处 《中国呼吸与危重监护杂志》 CAS CSCD 北大核心 2022年第8期550-555,共6页 Chinese Journal of Respiratory and Critical Care Medicine
基金 无锡市卫生计生委精准医疗项目(jzyx02) 2020太湖人才计划高端人才项目(2020THRC-GD-8) 无锡市卫生健康委青年项目(Q202003)。
关键词 肺移植 肺部感染 感染防治 Lung transplantation Pulmonary infection Infection prevention and treatment
  • 相关文献

参考文献4

二级参考文献37

  • 1马越,李景云,金少鸿.细菌耐药性监测分析中应注意的问题[J].中国抗生素杂志,2005,30(12):762-769. 被引量:41
  • 2GarnachoMontero J, AmayaVillar R, et al. Multiresistant Acinetobacter baumannii infections: epidemiology and management[J]. Curr Opin Infect Dis, 2010, 23(4):332-339.
  • 3Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrugresistant Acinetobacter baumannii[J]. Nat Rev Microbiol, 2007,5(12):939-951.
  • 4Peleg A Y,Seifert H,Paterson D L.Acinetobacter baumannii:emergence of a suceessful pathogen[J].Clin Microbiol Rev,2008,21(3):538-582.
  • 5MunozPrice L S,Weistein R A.Acinetobacter infection[J].N Engl J Med,2008,358(12):1271-1281.
  • 6Hwang YY, Liang R. Antifungal prophylaxis and treatment in patients with hematological malignancies[J]. Expert Revi Antiinfect Ther, 2010, 8(4): 397-404.
  • 7Rutar T, Cockerham KP. Periorbital zygomycosis (mucormycosis) treated with posaconazole [ J ]. Am J Ophthalmol, 2006, 142(1): 187-188.
  • 8Comely OA, Maertens J, Winston D J, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia[J]. N Engl J Med, 2007, 356(4): 348-359.
  • 9Vehreschild J J, Ruping MJ, Wisplinghoff H, et al. Clinical effectiveness of posaconazole prophylaxis in patients with acute myelogenous leukaemia (AML) : a 6 year experience of the Cologne AML cohort [J]. J Antimicrob Chemother, 2010, 65(7).. 1466-1471.
  • 10Sanchez-Ortega I, Patino B, Arnan M, et al. Clinical efficacy and safety of primary antifungal prophylaxis with posaeonazole vs itraeonazole in allogeneie blood and marrow transplantationI-Jl. Bone Marrow transplant, 2011, 46 (5) : 733-739.

共引文献61

同被引文献80

引证文献8

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部